The individual disease evolution of multiple sclerosis (MS) is very different from one patient to another. Therefore, the prediction of long-term disability evolution is difficult based on only clinical information. Magnetic resonance imaging (MRI) provides a very efficient tool to distinguish between healthy and abnormal brain tissue, monitor disease evolution, and help decision-making for personalized treatment of MS patients.
INTRODUCTION
Multiple sclerosis (MS) is the most frequent disabling neurological disease in young adults.
While its etiology remains unknown, MS is a demyelinating, inflammatory, and chronic disease of the central nervous system. The evolution of the disease and the risk of developing permanent disability are very different from one patient to another [Goldenberg, 2012] . Thus, today neurologists' challenge is to predict the evolution of individual disability using clinical, biological, and imaging data. According to Lublin [Lublin, 2014] ., 15% of MS patients start with PP that is characterized by continuous worsening of symptoms without relapses since diagnosis period.
In addition to clinical examination, magnetic resonance imaging (MRI) helps in diagnosing MS and monitoring MS evolution. Conventional MRI (such as T1-weighted and T2-weighted imaging) is very sensitive in detecting pathological tissue damage and obtaining valuable predictive information on disease evolution Fisniku et al., 2008] .
Lesion load (LL) and grey matter volume are important markers in evaluating the demyelination level, also axonal and neuronal damage [Peterson et al., 2001; Minneboo et al., 2009 ]. However, advanced MRI techniques, such as Diffusion Tensor Imaging (DTI) and MR Spectroscopic Imaging, have a better sensitivity and specificity in detecting white. Matter (WM) microstructural damages than conventional imaging [Ge et al., 2004; Sbardella et al., 2013 ] because of the complementary information based on diffusion and metabolic alterations . Besides, DTI performs well to distinguish MS subtypes because MS patients from different subtypes show specific diffusivity patterns [Sbardella et al., 2013] . Thus, we propose to use DTI data jointly with conventional imaging.
Among DTI measurements, fractional anisotropy (FA) measure was chosen because it is very sensitive in detecting microscopic changes related to inflammation [Hannoun et al., 2012] .
MS affects white matter tissue and lesions appear mostly around ventricles in periventricular white matter. The floor of the lateral ventricles forms a region called Corpus Callosum (CC), one of the regions that is frequently affected by MS lesions [Barnard, 1974;  The main objective of the present study is to develop a generalizable predictive model of disability evolution in MS patients, considering unobserved subgroups (different meanevolution profiles). Therefore, the latent class linear mixed model was used to predict EDSS trajectories over 5 years, using clinical, biological and imaging data collected at the study onset. All demographic, clinical and imaging variables were used in the fixed argument during the choice of the best combination. Besides, age at study onset was used as the variable that exerts the individual effect (in the random argument) in all models because there was a great inter-patient variability in terms of age at study onset.
Materials and Methods

Patients
First, the clinical model was established with age, disease duration, T25FW, 9HPT at study onset, and time in the fixed argument. Second, the imaging model was established with GMV, LL, and FA in the fixed argument. Third, the imaging variables were added one by one, two by two, or all three together with the clinical variables into the clinical model to obtain the combined models. Finally, the clinical, imaging, and combined models were compared using the BIC criterion, knowing that a lower BIC indicates a better fit of the model. Further, AIC, log-likelihood and the mean of the posterior probabilities were also reported in this study to examine the goodness of fit and allow result comparisons with previous studies.
Statistical analyses
Because most data did not follow the normal distribution, medians, 1st, and 3rd quartiles were used to describe the data. Consequently, non-parametric statistical tests were used to examine differences in demographic, clinical, and imaging data among the patients of the four clinical subtypes. The Kruskal-Wallis test was used first to check whether the distributions of variables were significantly different. In case of significant difference, a Mann-Whitney U test was used to compare subtype medians two by two. Statistical significance was considered at p<0.05.
RESULTS
EDSS at study onset was significantly higher for PP and SP patients compared to CIS and RR patients (p-value <0.05). However, there was no significant difference between the EDSS of PP and SP patients (p-value= 0.61). PP patients were significantly older than other patients at study onset (p-value <0.05). The disease duration was similar for RR and PP patients (p-value= 0.51) and was significantly greater for SP patients (p-value <0.05). T25FW was significantly different among all clinical subtypes, and PP patients had the greatest T25FW values at study onset. There was no significant difference between the 9HPT measurements of CIS and RR patients (p-value = 0.11), nor PP and SP patients (p-value =0.63). Also, the GMV was similar for CIS and RR patients (p-value = 0.42) as well as for PP and SP patients (pvalue = 0.21). However, the GMV was significantly greater for CIS and RR patients compared to PP and SP patients (p-value <0.05). There was no significant difference in LL between RR and PP patients (p-value=0.86). The LL was significantly lower for CIS patients and greater for SP patients (p-value <0.05). SP patients had the greatest FA value compared to the other clinical subtypes (p-value <0.05). The model with two latent classes that gave the lowest BIC value had 1) the time as the variable with a specific effect on each latent class (in the mixture argument), and 2) a linear time function (in the fixed argument) gave the lowest BIC value (see Appendix).
Therefore, in the following sections, the models that included time in the mixture argument and age in the random argument will be discussed BIC results suggest that the clinical model offers a slightly better fit than the imaging and combined models. All models had mean posterior probabilities of over 0. The clinical model will be presented hereafter as this model gave the best BIC result.
The effect of all clinical was significantly different than zero in the clinical model. The parameter coefficient of the time was given for each latent class and it was significantly different from zero for one of the classes. Specifically, the more time elapsed, the greater the EDSS in Class 1. Also, the parameter coefficients of disease duration, age, T25FW, and 9HPT
were positive, and this means that a unit increase of these variables at the study onset had an effect to increase EDSS at the study onset. Figure 1 shows the predicted points and observed mean trajectories obtained with the clinical model, and Table 4 gives the classification of the patients in the latent classes. The graph shows that the evolution of EDSS is stable for Class 2. However, Class 1 included all clinical subtypes except CIS and shows a severe evolution of the clinical score. Also, the time was significantly different than zero for this class. Moreover, the predicted points were closer to the observed mean trajectory for Class 2, and Class 1 contained a smaller number of patients compared to Class 2 (12% vs. 88%). The low number of patients in Class 1 might be the cause of the less accurate prediction and the higher difference between the predicted and observed mean trajectories. The performance of the clinical model was also analyzed based on the prediction at 5 years after the study onset. The predicted and observed EDSS scores were presented in Figure 2 . In concordance with the previous results, the patients in Class 1 showed higher predicted and observed EDSS scores compared to the patients in Class 2. The clinical model showed high accuracy with an R 2 of 0.945 and RMSE of 0.534. The imaging and combined models gave similar results with an R 2 over 0.9 and RMSE of less than 0.6. The prediction was poor for the patients with lower EDSS scores (i.e. lower than EDSS 4). The patients with lower EDSS scores might be classified in another group that would lead to a better prediction. The patients in the two latent classes were compared based on EDSS, age, disease duration, T25FW, 9HPT, GMV, LL, and FA at study onset. Table 5 shows that the LL was significantly greater in the class, in which the patients show an aggressive disability progression (Class 1) (p-value<0.05). However, other demographic, clinical, and imaging variables were not significantly different between the two latent classes (p-value > 0.05 for all variables). Figure 3 demonstrates that the LL in Class 1 showed a normal distribution, whereas the LL was asymptotically distributed in Class 2. Most of the patients in Class 2 had less LL compared to Class 1. Also, the median of the LL in Class 1 was approximately two times higher than the median of LL in Class 2. Imaging and combined models Table 6 shows that the effect of the GMV was significantly different from zero (p-value <0.05) in the imaging model but not significant (p-value=0.062) in the combined model. Time in Class 1, as well as the demographic and clinical variables, were still significant in the combined model (p-value <0.05). However, the imaging variables did not have any significant effect, and the parameter coefficients of these parameters were not significantly different than zero (p-value GMV =0.062, p-value LL =0.723, and p-value FA =0.231). The EDSS evolution trajectories and the classification of the patients that were found by imaging and combined models were similar to the results of the clinical model (See Supplementary   Material) . There was only one more SP patient classified in Class 2 (with stable evolution) instead of Class 1 (with severe evolution) in the combined model results. worsening. However, 12% of the patients were assigned to the class with severe disability progression. Assigning patients to either of these two latent classes (stable or severe) may help treatment decisions. For example, patients with a probable severe evolution would benefit from second-line therapies.
EDSS 4 is known to be the threshold of limited walking disability, even though a patient may be able to walk more than 500 m. The predicted EDSS values were around EDSS 4 at the study onset in the three latent classes, and then each class evolved differently. Thus, our predictions were able to distinguish the patients who might have a severe, stable, or moderate evolution after reaching the threshold of limited walking disability.
GMV had a significant role in the imaging model in our study. Indeed, previous studies have shown that GMV may constitute a good marker of the risk of increased However, the white matter LL measured in our study did not play a significant role, neither in the imaging nor in the combined models.
One limitation of the present work was the use of the LL measured in the whole WM rather than locally. The location and size of the lesion are very important markers of clinical disability. A future modeling study on the evolution of clinical disability may consider the focal LL in WM and GM.
To conclude, the latent class linear mixed model allowed building a well-fitted predictive model for disability evolution in patients with MS, and this model showed highly accurate results. The model developed here is highly promising in predicting individual long-term disability evolution in all clinical subtypes of MS.
